Amplification of T cell-mediated immune responses by antibody-cytokine fusion proteins.
Lode
H N
HN
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Xiang
R
R
Gillies
S D
SD
Reisfeld
R A
RA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines / Q000008:administration & dosage; D016207:Cytokines / Q000008:administration & dosage*; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000008:administration & dosage; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000276:immunology
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines; D005732:Gangliosides; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C019403:ganglioside, GD2